These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 35450351)

  • 1. Selective A
    Suresh RR; Gao ZG; Salmaso V; Chen E; Campbell RG; Poe RB; Liston TE; Jacobson KA
    ACS Med Chem Lett; 2022 Apr; 13(4):623-631. PubMed ID: 35450351
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacological characterization of DPTN and other selective A
    Gao ZG; Suresh RR; Jacobson KA
    Purinergic Signal; 2021 Dec; 17(4):737-746. PubMed ID: 34713378
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Structure activity relationship of 2-arylalkynyl-adenine derivatives as human A
    Yu J; Mannes P; Jung YH; Ciancetta A; Bitant A; Lieberman DI; Khaznadar S; Auchampach JA; Gao ZG; Jacobson KA
    Medchemcomm; 2018 Nov; 9(11):1920-1932. PubMed ID: 30568760
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Selectivity is species-dependent: Characterization of standard agonists and antagonists at human, rat, and mouse adenosine receptors.
    Alnouri MW; Jepards S; Casari A; Schiedel AC; Hinz S; Müller CE
    Purinergic Signal; 2015 Sep; 11(3):389-407. PubMed ID: 26126429
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 125I-4-aminobenzyl-5'-N-methylcarboxamidoadenosine, a high affinity radioligand for the rat A3 adenosine receptor.
    Olah ME; Gallo-Rodriguez C; Jacobson KA; Stiles GL
    Mol Pharmacol; 1994 May; 45(5):978-82. PubMed ID: 8190112
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Species dependence of A
    Gao ZG; Auchampach JA; Jacobson KA
    Purinergic Signal; 2023 Sep; 19(3):523-550. PubMed ID: 36538251
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rigidified A3 Adenosine Receptor Agonists: 1-Deazaadenine Modification Maintains High in Vivo Efficacy.
    Tosh DK; Crane S; Chen Z; Paoletta S; Gao ZG; Gizewski E; Auchampach JA; Salvemini D; Jacobson KA
    ACS Med Chem Lett; 2015 Jul; 6(7):804-8. PubMed ID: 26191370
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis and pharmacological characterization of [(125)I]MRS5127, a high affinity, selective agonist radioligand for the A3 adenosine receptor.
    Auchampach JA; Gizewski ET; Wan TC; de Castro S; Brown GG; Jacobson KA
    Biochem Pharmacol; 2010 Apr; 79(7):967-73. PubMed ID: 19917269
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis, CoMFA analysis, and receptor docking of 3,5-diacyl-2, 4-dialkylpyridine derivatives as selective A3 adenosine receptor antagonists.
    Li AH; Moro S; Forsyth N; Melman N; Ji XD; Jacobson KA
    J Med Chem; 1999 Feb; 42(4):706-21. PubMed ID: 10052977
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Thiazole and thiadiazole analogues as a novel class of adenosine receptor antagonists.
    van Muijlwijk-Koezen JE; Timmerman H; Vollinga RC; Frijtag von Drabbe Künzel J; de Groote M; Visser S; IJzerman AP
    J Med Chem; 2001 Mar; 44(5):749-62. PubMed ID: 11262085
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Structure-activity relationships and molecular modeling of 3, 5-diacyl-2,4-dialkylpyridine derivatives as selective A3 adenosine receptor antagonists.
    Li AH; Moro S; Melman N; Ji XD; Jacobson KA
    J Med Chem; 1998 Aug; 41(17):3186-201. PubMed ID: 9703464
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Exploring the Role of N
    Petrelli R; Scortichini M; Kachler S; Boccella S; Cerchia C; Torquati I; Del Bello F; Salvemini D; Novellino E; Luongo L; Maione S; Jacobson KA; Lavecchia A; Klotz KN; Cappellacci L
    J Med Chem; 2017 May; 60(10):4327-4341. PubMed ID: 28447789
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis and pharmacological characterization of [(125)I]MRS1898, a high-affinity, selective radioligand for the rat A(3) adenosine receptor.
    Gao ZG; Teng B; Wu H; Joshi BV; Griffiths GL; Jacobson KA
    Purinergic Signal; 2009 Mar; 5(1):31-7. PubMed ID: 18528782
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 2-triazole-substituted adenosines: a new class of selective A3 adenosine receptor agonists, partial agonists, and antagonists.
    Cosyn L; Palaniappan KK; Kim SK; Duong HT; Gao ZG; Jacobson KA; Van Calenbergh S
    J Med Chem; 2006 Dec; 49(25):7373-83. PubMed ID: 17149867
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fluorescent A
    Toti KS; Campbell RG; Lee H; Salmaso V; Suresh RR; Gao ZG; Jacobson KA
    Purinergic Signal; 2023 Sep; 19(3):565-578. PubMed ID: 35687212
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Design, synthesis, and biological evaluation of new 8-heterocyclic xanthine derivatives as highly potent and selective human A2B adenosine receptor antagonists.
    Baraldi PG; Tabrizi MA; Preti D; Bovero A; Romagnoli R; Fruttarolo F; Zaid NA; Moorman AR; Varani K; Gessi S; Merighi S; Borea PA
    J Med Chem; 2004 Mar; 47(6):1434-47. PubMed ID: 14998332
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization by flow cytometry of fluorescent, selective agonist probes of the A(3) adenosine receptor.
    Kozma E; Gizewski ET; Tosh DK; Squarcialupi L; Auchampach JA; Jacobson KA
    Biochem Pharmacol; 2013 Apr; 85(8):1171-81. PubMed ID: 23376019
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [3H]HEMADO--a novel tritiated agonist selective for the human adenosine A3 receptor.
    Klotz KN; Falgner N; Kachler S; Lambertucci C; Vittori S; Volpini R; Cristalli G
    Eur J Pharmacol; 2007 Feb; 556(1-3):14-8. PubMed ID: 17126322
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nucleoside-derived antagonists to A3 adenosine receptors lower mouse intraocular pressure and act across species.
    Wang Z; Do CW; Avila MY; Peterson-Yantorno K; Stone RA; Gao ZG; Joshi B; Besada P; Jeong LS; Jacobson KA; Civan MM
    Exp Eye Res; 2010 Jan; 90(1):146-54. PubMed ID: 19878673
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis and biological activities of 4-phenyl-5-pyridyl-1,3-thiazole derivatives as selective adenosine A3 antagonists.
    Miwatashi S; Arikawa Y; Matsumoto T; Uga K; Kanzaki N; Imai YN; Ohkawa S
    Chem Pharm Bull (Tokyo); 2008 Aug; 56(8):1126-37. PubMed ID: 18670113
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.